JANUS HENDERSON INVESTORS US LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON INVESTORS US LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2017$40,125,000
+82.8%
1,709,729
-4.4%
0.03%
+83.3%
Q4 2016$21,946,000
-30.8%
1,788,352
-3.2%
0.02%
-33.3%
Q3 2016$31,723,000
+7.6%
1,846,526
-10.9%
0.03%
+8.0%
Q2 2016$29,481,000
-1.6%
2,071,804
-4.9%
0.02%
-3.8%
Q1 2016$29,960,000
-25.0%
2,178,797
-8.0%
0.03%
-23.5%
Q4 2015$39,921,000
-20.7%
2,369,215
-48.4%
0.03%
+47.8%
Q3 2015$50,340,000
+122.1%
4,593,096
+153.5%
0.02%
+21.1%
Q2 2015$22,664,000
+38.4%
1,811,704
+21.7%
0.02%
+46.2%
Q1 2015$16,374,000
-16.4%
1,488,524
+17.9%
0.01%
-23.5%
Q4 2014$19,575,000
+37.3%
1,262,900
+6.9%
0.02%
+30.8%
Q3 2014$14,255,000
+8.7%
1,181,048
+15.5%
0.01%
+8.3%
Q2 2014$13,114,000
-2.6%
1,022,959
-7.9%
0.01%
-7.7%
Q1 2014$13,464,000
+26.4%
1,110,928
+18.4%
0.01%
+30.0%
Q4 2013$10,651,000
-1.3%
938,376
-9.1%
0.01%
-9.1%
Q3 2013$10,786,000
-30.2%
1,032,134
-22.9%
0.01%
-31.2%
Q2 2013$15,456,0001,338,1780.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2014
NameSharesValueWeighting ↓
CM Management, LLC 750,000$930,0000.85%
Deep Track Capital, LP 17,875,498$22,165,6180.66%
Acuitas Investments, LLC 879,904$1,091,0810.58%
TCG Crossover Management, LLC 4,000,000$4,960,0000.52%
Almitas Capital LLC 920,225$1,141,0790.47%
Monaco Asset Management SAM 2,166,432$2,686,3760.43%
Shay Capital LLC 1,840,377$2,282,0670.32%
Nantahala Capital Management 4,110,000$5,096,4000.30%
Ikarian Capital, LLC 1,312,405$1,627,3820.28%
SAMLYN CAPITAL, LLC 9,457,887$11,727,7810.20%
View complete list of NEKTAR THERAPEUTICS shareholders